American Journal Of Gastroenterology - Author Podcasts

John Pandolfino, MD, MS, co-author of a recent study examining the effect of PPIs on laryngeal reflux symptoms, talks with AJG co-editor Dr. Brian Lacy about why laryngopharyngeal reflux symptoms are so difficult to diagnose and treat, whether PPIs are the correct approach, and how acid exposure and laryngeal pH factor into the equation. (18:16)

Gwo-tzer Ho, PhD, co-author of a recent review of recent developments for precision medicine in IBD talks with AJG co-editor Dr. Brian Lacy about the definition and scope of precision medicine, newly discovered IBD biomarkers that could be used to guide precision therapies, and the practical and ethical implications of these new developments. (21:38)

Dr. Chey, co-author of new research comparing the effectiveness of the low FODMAP diet versus a modified NICE diet for IBS-D, speaks with AJG co-Editor in Chief Dr. Brennan Spiegel about improvements in bloating and abdominal pain found with the low FODMAP diet, the value of individual symptom response compared to an overall “adequate relief” end point, and practical advice for guiding patients through the low FODMAP diet process. (24:05)

Dr. Gupta, co-author of recent study examining the impact of small financial incentives for completion of FIT testing, speaks with AJG co-Editor in Chief Dr. Brennan Spiegel about why use of financial incentives to encourage health behavior is not always effective, and the behavioral economics underlying this research. This article was published in the recent Negative Issue of AJG. (15:43)

C. Mel Wilcox, MD, MSPH, co-author of new research on the causes, response to therapy, and long-term outcome of idiopathic pancreatitis, speaks with AJG co-Editor in Chief Dr. Brian Lacy about the evolving definition of idiopathic pancreatitis, the role of EUS vs MRCP in its diagnosis, and when you should consider pancreas divisum or autoimmune disorders in your etiology. (12:35)

Austin Chiang, MD, co-author of a recent Red Section article on GI ontology in social media, speaks with AJG co-Editor in Chief Dr. Brian Lacy about the benefits and logistics of using social media, specifically Twitter, in a GI practice, how new users can best take the first steps. (11:22)

William Lee, MD, co-author of an new article comparing complementary and alternative medicine (CAM)-induced liver injury to that caused by prescription medications, speaks with AJG co-Editor in Chief Dr. Brian Lacy about the definition of CAM, the regulatory approval process (or lack thereof) for CAM compared to prescription medication, and the most frequent CAM and prescription offenders for drug-induced liver injury. Dr. Lee also provides advice for clinicians trying to diagnose and counsel patients with suspected CAM-induced liver injury. (15:50)

Mark S. Riddle, MD, DrPH, co-author of the new ACG Clinical Guideline, speaks with AJG co-Editor in Chief Dr. Brian Lacy about the public health threat of acute diarrheal infections, the most effective diagnostic tests, and the appropriateness of antibiotics. The role of oral rehydration, probiotics, and anti-diarrheal medication is also discussed. (19:51)

Lisa Strate, MD, MPH, FACG, co-author of the new ACG Clinical Guideline, speaks with AJG co-Editor in Chief Dr. Brennan Spiegel about the timing of endoscopy for management of lower GI bleeding, how to assess high-risk patients for whom colonoscopy should not be performed, and the important questions surrounding the topic that remain unanswered in the current literature. (18:22)

Steve McClave, MD, co-author of the new ACG Clinical Guideline, speaks with AJG co-Editor in Chief Dr. Brian Lacy about how to recognize nutritionally deficient patients, the most common deficiencies by condition, how to determine if a patient will tolerate enteral feeds, and the pros and cons of orgastric, nasogastric, and jejunal feeding. Dr. McClave dispels some common myths, provides advice on peripheral PN (Don’t do it!), and emphasizes the invaluable support GIs can provide for the nutritional team. (16:25)

William D. Chey, MD, FACG, presenter of the 2015 David Sun Lecture and author of a recently published review of the same topic, speaks with AJG co-Editor-in-Chief Dr. Brennan Spiegel about the evolution of food from sustenance and medicine to entertainment and enjoyment and the gradual shift back toward food as medicine and therapy for disease. Learn more about the complex interplay between food and GI symptoms and the FODMAP diet as a promising treatment approach. The emerging academic focus on diet and nutrition in GI care and the essential role of dietitians in the lives of IBS patients are also discussed. (25:35)

Tram T. Tran, MD, FACG, FAASLD, co-author of the new ACG Clinical Guideline on the management of liver diseases in pregnant women, speaks with AJG co-Editor in Chief Dr. Brennan Spiegel about the liver function tests that may be abnormal during pregnancy, which ones to be concerned about, and how to best pursue imaging or endoscopic follow-up in pregnant women. Advice for patients who are pregnant or who wish to become pregnant is also included. (21:18)

Jasmohan S. Bajaj, MD, co-author of a multi-center study validating a new app to diagnose minimal hepatic encephalopathy (MHE), speaks with AJG co-Editor in Chief Dr. Brennan Spiegel about the difficulty diagnosing MHE in cirrhotic patients, and the importance of a valid, rapid, and accessible diagnostic tool for this disabling and dangerous condition. Dr. Bajaj also discusses the difficulty of creating validated, user-friendly apps that provide both accurate diagnostics for patients and their doctors as well as usable data for researchers. (22:33)

Nicholas Shaheen, MD, MPH, FACG, co-author of the new ACG Clinical Guideline on the management of Barrett’s Esophagus (BE), speaks with AJG co-Editor in Chief Dr. Brian Lacy about the changing definition of BE and reasons for a new guideline. Learn more about biopsy strategies, which patients should be screened, and proper surveillance strategies once a diagnosis is made. Treatment and prevention strategies are also discussed. (16:20)

Christopher Almario, MD, MSHPM, co-author of a recent article examining the cost-effectiveness of various approaches for preventing transmission of carbapenem-resistant Enterobacteriaceae (CRE) through ERCP endoscopes, discusses the genesis of the study and the finding that newly issued FDA recommendations for endoscope reprocessing were most cost-effective compared to the other approaches studied. Dr. Almario explains why a “do nothing strategy” was not included in the model, and addresses other underlying assumptions of the analysis. (20:39)

Tine Jess MD, MSc, co-author of a recent article about the risk of invasive pneumococcal disease (IPD) in IBD patients, talks with AJG Co-Editor Dr. Paul Moayyedi about the increased risk of IPD as long as 4 years prior to IBD diagnosis, the risk of IPD associated with various IBD drug therapies, including the lack of risk associated with biologic therapies and oral corticosteroids, and whether physicians should be routinely offering the pneumococcal vaccine to IBD patients. (16:28)

Sachin Wani MD, co-author of a recent article about on-site cytopathology evaluation during EUS-FNA for pancreatic masses, talks with AJG Co-Editor Dr. William Chey about why EUS has been come such an important part of evaluation for pancreatic masses and cancer, the benefits and limitations of on-site cytopathology, an presents advice on cost-minimization and quality indicator adherence. (18:21)

Lauren Gerson, MD, MSc, FACG, co-author of the new ACG Clinical Guideline on small bowel bleeding talks with AJG Co-Editor Dr. Paul Moayyedi about recommended diagnostic techniques, including second look endoscopy, capsule endoscopy, push enteroscopy, and double-balloon enteroscopy. Efficacy of hormonal therapies, somatostatin analogs, biologic therapy, and angiogenic therapy is discussed, as well as the role of anticoagulants in the management of patients with obscure bleeding. (20:28)

Peter Higgins, MD, PhD, co-author of a recent editorial regarding the use of chromoendoscopy surveillance in IBD and ulcerative colitis, talks with AJG Co-Editor Dr. William Chey about the relationship between chronic ulcerative colitis and dysplasia, the real rate of dysplasia development in these patients, and how frequently surveillance colonoscopy should be performed. Dr. Higgins also summarizes recent research on the use of chromoendoscopy for surveillance and weighs the costs and benefits of applying this procedure to IBD patients in clinical practice. (21:08)

Keith D. Lindor, MD, FACG, co-author of the new ACG Clinical Guideline on primary sclerosing cholangitis talks with AJG Co-Editor Dr. Paul Moayyedi about recommended diagnostic techniques, symptom management strategies, and the role of liver transplantation. Recommendations for colon and cholangiocarcinoma surveillance are also discussed. (18:18)